SurvivorNet on MSN
After A Bladder Cancer Diagnosis At 39, Groundbreaking New Treatment Option Inlexzo Allows Texas Man To Avoid Surgery & Get Back To An Active Life
Jimi Stewart, a rollerblading enthusiast from Austin, Texas, was diagnosed with a type of non-muscle invasive bladder cancer ...
As new therapies emerge, particularly for non-muscle invasive disease, clinicians and patients are faced with increasingly complex decisions regarding efficacy, cost, and accessibility. In this ...
A large real-world study examines outcomes and treatment patterns among patients with non-muscle-invasive bladder cancer treated with BCG.
Whether you’re catching up with friends or soaking up the sun in your own back yard, the last thing you want to worry about ...
The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...
SurvivorNet on MSN
Inlexzo: A new option for bladder cancer patients when BCG immunotherapy stops working
If you or a loved one has been diagnosed with BCG-unresponsive non-muscle invasive bladder cancer and are exploring your ...
Senior male patient in hospital gown seen through CAT scan machine. Male patient at clinic for MRI scan. The 2023 guideline on managing muscle-invasive bladder cancer offers evidence-based ...
NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...
( NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced it will present new treatment comparison results evaluating ANKTIVA ® (nogapendekin alfa inbakicept-pmln) plus Bacillus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results